BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$1.38
Tradestie Score
59
Market Cap
$50.49M
Revenue Growth
0.2%
Analyst Upside
+914.5%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.86
$1.02B - 62 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.18
$711.32M - 54 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 59 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.50
$543.32M - 57 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$2.08
$275.13M - 55 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.33
$237.15M 6.6 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$25.10
$212.23M - 55 Compare
ATRA Atara Biotherapeutics, Inc
$11.65
$101.48M - 57 Compare
KPTI Karyopharm Therapeutics Inc.
$9.60
$53.85M - 54 Compare
KYNB KYNB
$7.63
- - 58 Compare

Data updated: Jul 05, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry